Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial update involving a monoclonal antibody therapy for lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: University of Nebraska | Conditions: Lymphoma | Phase 3 | Status: TERMINATED